Conagra Q4 Earnings Miss Estimates, Sales Decline 4.3% Y/Y

Conagra Brands (CAG) reported a challenging Q4 fiscal 2025, with net sales declining 4.3% year-over-year to $2.78 billion and adjusted EPS falling 8.2% to $0.56, both missing consensus estimates. Organic sales decreased 3.5% due to softer demand and lower volumes. The company provided a cautious outlook for fiscal 2026, projecting adjusted EPS of $1.70-$1.85, a significant reduction from FY25's $2.30, and organic sales growth ranging from -1% to +1%, reflecting ongoing headwinds. This performance and guidance have contributed to a 23.7% decline in CAG shares over the last three months, indicating investor concern.

Analysis

Conagra Brands (CAG) reported a fundamentally weak fourth-quarter for fiscal 2025, with both revenue and earnings missing consensus estimates and declining year-over-year. Net sales fell 4.3% to $2.78 billion, while adjusted EPS dropped 8.2% to $0.56. The core issue stems from a 3.5% decline in organic sales, driven by a 2.5% decrease in volume and a 1.0% negative price/mix, indicating significant pressure from softening consumer demand. This top-line weakness translated into severe margin compression, with the adjusted gross margin contracting 184 basis points to 25.8% as cost inflation and lower operating leverage negated productivity gains. The negative performance was broad-based, with organic sales falling across the major Grocery & Snacks and Refrigerated & Frozen segments. The forward guidance for fiscal 2026 is particularly concerning, projecting adjusted EPS between $1.70 and $1.85—a substantial decrease from the $2.30 reported in fiscal 2025—and anemic organic sales growth between -1% and +1%. This outlook suggests management expects no near-term recovery, a sentiment reflected in the stock's 23.7% decline over the past three months, starkly underperforming the industry's 2% drop.

Key Decisions for Investors

• Given the significant earnings miss, contracting gross margins, and a deeply pessimistic fiscal 2026 forecast, investors should exercise extreme caution as a turnaround does not appear imminent.
• Investors should closely monitor for a stabilization in sales volumes and a recovery in gross margins, as these are the primary indicators of the company's operational distress.
• The dividend appears supported by strong fiscal 2025 free cash flow of $1.3 billion, but the projected sharp decline in fiscal 2026 earnings introduces risk to its long-term sustainability if performance does not improve.
• Considering the stock's significant underperformance and the positive outlook cited for peers like POST and THS, investors seeking exposure to this sector may find better relative value and growth prospects elsewhere.